Antiretroviral therapies in women after single-dose nevirapine exposure
Get This Resource
English: Web Page
Summary
Full text available. This study examined ART regimens for women who took nevirapine to prevent mother-to-child-transmission. The authors concluded that women with prior exposure to peripartum single-dose nevirapine (but not in those without prior exposure), ritonavir-boosted lopinavir plus tenofovir–emtricitabine was superior to nevirapine plus tenofovir–emtricitabine for initial antiretroviral therapy.
|
|
Massachusetts Medical Society |
|
|
English |
|
|
Web Page |
|
|
Global |
|
|
Doctors/Physicians, Policymakers, Program Managers, Researchers, Nurses, Other Healthcare Workers |
|
|
Perinatal Interventions, Antiretroviral Treatment & Complications |
|
|
Journal Articles |